Conatus Pharmaceuticals Initiates Phase 2 Trial in Patients with Liver Cirrhosis And Hypertension

Conatus-Pharma-logo
Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the initiation of a Phase 2 clinical trial of its lead drug candidate, emricasan, in patients with liver cirrhosis (LC), and the initiation of a separate exploratory... more →
Posted in: Press

Concert Pharmaceuticals Achieves $2M Milestone Collaborating With Avanir Pharmaceuticals

conpharma
Concert Pharmaceuticals, Inc. (CNCE) today announced that it has achieved a $2 million milestone under its development and license agreement with Avanir Pharmaceuticals, Inc. for the clinical progression of AVP-786. The milestone is a result of Avanir initiating dosing in a Phase 2 clinical trial with AVP-786 for the adjunctive treatment... more →
Posted in: Press

Research Update On Ml Capital Group, Inc. By Goldman Small Cap Research

106
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research update on ML Capital Group Inc. To read more visit http://finance.yahoo.com/news/goldman-small-cap-research-issues-120000965.html more →
Posted in: Investing

Pot Plants Consume California Water Supply Creating Drought

29
In a map of Humboldt County, California, provided by law enforcement, each pin indicates a marijuana grow site that police have located. Yellow pins are discovered sites; red pins are sites that have been raided. “We get those calls daily. People are upset. Somebody has dried up a stream, somebody is building a road across... more →
Posted in: Investing

Research Update Of Goldman Small Cap

78
In the Goldman Opportunity Research report on the Company, analyst Rob Goldman outlines his investment thesis. This under-the-radar company has a number of trends in its favor. With a steady increase in the number of its distribution and medical marijuana dispensary channels, the Company has already begun to book meaningful initial... more →
Posted in: Investing

Medbox, Inc. Announces the Launch of its New Investor Relations Website

MedBoxLogo
Medbox, Inc. (MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, unveiled its new Investor Relations website. The site, www.medbox.com, incorporates numerous features to make browsing for investment information a much faster and informative... more →
Posted in: Press

mCig, Inc. Obtains Registered Trademark Approval for mCig(R) and VitaCig(R) Brands

mcig
mCig, Inc. (MCIG) is pleased to announce that the United States Government Patent & Trademark Office (USPTO) has officially issued the following trademarks to the company: mCig(R) – Reg. No. 4591689 issued on August 26, 2014 covering electronic cigarettes, and lithium-ion batteries for electronic cigarettes. VitaCig(R)... more →
Posted in: Press

GreenLeaf Acquisition Expands Endexx’s Product Line Up

gwpharma-logo
The market for legalized marijuana in the United States is expected to surpass $8 billion by 2018, according to Marijuana Business Daily. In addition to the recreational legalization of marijuana in Colorado and Washington State, voters will have the opportunity to legalize the drug in Washington DC, Alaska and Oregon in November,... more →
Posted in: Press

Marijuana Penny Stocks Still Doomed & Growlife Is Still On A Halt

17
Let me explain again. I’ve repeatedly highlighted Growlife /quotes/zigman/11335612/delayed /quotes/nls/phot PHOT as a poster-child for this game in which the retail investor is always the mark , and late last week, holders of PHOT woke up to news that the SEC had finally gotten off their butt and was suspending trading in... more →
Posted in: Investing

Medical Marijuana Scams Abound, Warns Canada Securities Watchdog

222
Canada’s securities watchdog warned Monday against dud medical marijuana investments, saying stock prices of several shell companies have soared after simply announcing their “intention” to grow and sell pot. This follows a new government scheme starting on April 1 that banned home cultivation of medical marijuana... more →
Posted in: Investing
1 2 3 34